News Digest / Income Statements / Macy's Q2: Sales Down, Margins Pressured by Tariffs; Reimagine Stores and Buybacks

Macy's Q2: Sales Down, Margins Pressured by Tariffs; Reimagine Stores and Buybacks

StockInvest.us
05:09pm, Wednesday, Sep 10, 2025
Illustration by StockInvest.us

Macy's, Inc. (NYSE: M) - Q2 2025 snapshot (from Form 10‑Q for quarter ended August 2, 2025)

Quick summary - what's happening inside the company
* Management is executing "A Bold New Chapter": store reimaginings (Reimagine 125), luxury push (Bloomingdale's) and operational modernization (automation, AI pilots).
* Company is returning capital (dividends maintained; repurchased ~12.6M shares YTD for ~$151M) while refinancing and shortening some maturities with a $500M 7.375% note offering and $587M of redemptions/tenders in late July 2025.
* Liquidity: cash balance roughly $829M and an Amended & Extended ABL facility with ~$1,957M available borrowing capacity; management says liquidity and expected cash flows should cover needs for at least 12 months.
* Supply‑chain pressure and tariffs (notably higher tariffs on China imports) are active risks and have influenced pricing and margins.

Income statement - positives
* Comparable sales improving in target areas: Macy's, Inc. comparable sales +0.8% (owned basis) and +1.9% (O+L+M) in Q2 2025; go‑forward business comps stronger (owned +1.1%).
* Bloomingdale's and Bluemercury show strength: Bloomingdale's comps +3.6% (owned) and +5.7% (O+L+M); Bluemercury comps +1.2% (owned).
* Other revenue up: credit card revenue Q2 $153M vs $125M prior year (Q2), and YTD credit card revenue $306M vs $242M - credit portfolio contributing incremental revenue and profit share.
* Operating cost control: SG&A declined modestly (Q2 SG&A $1,944M vs $1,973M) despite investments in reimagine initiatives; adjusted EBITDA and core adjusted EBITDA remain positive ($393M and $377M for Q2 respectively).
* Operating cash flow improved materially: Net cash provided by operating activities YTD $255M vs $137M prior year.

Income statement - negatives
* Revenues and profitability down vs. prior year: Q2 net sales $4,812M (‑2.5% YoY), total revenue $4,999M (vs $5,096M).
* Significant downward pressure on margins: gross margin rate fell 80 basis points in Q2 to 39.7% (driven by proactive markdowns to reduce inventory and the flow‑through impact of higher tariffs).
* Operating income and net income declined: Q2 operating income $149M vs $222M prior year; net income $87M vs $150M; diluted EPS $0.31 vs $0.53.
* YTD results show similar deterioration: 26‑week net income $124M vs $212M prior year; diluted EPS $0.44 vs $0.75.
* One‑time and non‑core charges: impairment/restructuring costs ($22M in Q2, $30M YTD) and a $13M loss on extinguishment of debt in Q2 related to the debt refinancing transactions.
* Inventory and working capital: company took proactive markdowns (inventory write actions) to improve inventory health; inventories remain large (~$4,342M) and current liabilities rose (accounts payable and accrued liabilities higher vs prior year at certain dates).
* Effective tax rate increased YTD to 31.9% (vs 27.4% prior year), increasing after‑tax drag on earnings.

Key numbers & metrics (selected, millions unless noted)
* Q2 2025 net sales: $4,812 (Q2 2024: $4,937) - Δ: ‑$125 (‑2.5%).
* Q2 2025 total revenue: $4,999 (Q2 2024: $5,096).
* Q2 2025 gross margin: $1,912 (39.7%) vs $1,999 (40.5%) prior year - down 80 bps.
* Q2 2025 operating income: $149 vs $222 prior year.
* Q2 2025 net income: $87 vs $150 prior year; diluted EPS $0.31 vs $0.53.
* 26‑week net sales: $9,411 vs $9,783 prior year (‑3.8%); 26‑week net income $124 vs $212; diluted EPS $0.44 vs $0.75.
* Cash & cash equivalents (Aug 2, 2025): $829; total assets $15,551; shareholders' equity $4,451.
* Long‑term debt (Aug 2, 2025): $2,432 (down from $2,993 at Aug 3, 2024); fair value of long‑term debt ≈ $2,336.
* Inventories: $4,342 (Feb 1, 2025: $4,468; Aug 3, 2024: $4,378).
* ABL availability: ~$1,957M (after ~$143M letters of credit outstanding).
* Share repurchases YTD: ~12.6M shares for ~$151M; remaining repurchase authorization ~$1,224M.
* Shares outstanding (Aug 30, 2025): 268,505,751 shares.

Capital structure & recent financing
* July 29, 2025: issued $500M of 7.375% senior notes due 2033; used proceeds plus cash to redeem/repurchase about $587M of older notes/debentures and pay fees - generated a $13M loss on extinguishment.
* Amended ABL: reduced facility to $2,100M but extended maturity to April 2030 and lowered certain fees; no borrowings under ABL at quarter end.
* Interest expense declined YoY (Q2 interest expense net $25 vs $31) due to prior refinancing activity, though new long‑dated paper carries ~7.375% coupon.

Operational highlights & risks
* Reimagine 125 stores outperforming the fleet on traffic, AOV and NPS; Macy's NPS at record second‑quarter level.
* Digital sales mix: ~31% of net sales in Q2 2025 (up from 29% prior year) - omnichannel is material to results.
* Major risks called out by management: tariffs (including recent U.S. tariffs on many trading partners), supply‑chain disruptions, vendor financing risk, and geopolitical uncertainty - these could further pressure margins and availability.

Bottom line - what to watch next
* Margin recovery: monitor whether markdowns were sufficient and whether gross margin stabilizes as inventory clears and sourcing/pricing actions take hold.
* Sales trajectory at reimagined Macy's locations and Bloomingdale's: continued comp improvement there is key to offset store closures and broader Macy's weakness.
* Debt profile and interest costs: track cash interest paid (YTD interest paid $113M) and any further debt exchanges/redemptions that could create one‑time charges.
* Tariff and supply‑chain impact: magnitude and duration of tariffs and vendor responses will materially affect cost of goods and pricing power.
* Free cash flow and buybacks vs reinvestment: management is balancing repurchases with capex (~$343M YTD) and dividends ($100M YTD); watch cash flow conversion and remaining repurchase cushion.

Source: Macy's, Inc. Form 10‑Q (quarter ended August 2, 2025). Numbers shown as reported by the company.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.